Knock out VGLL4 in valvar endothelial cells leads to hypertrophy and compromised heart function on later stage. by Wei Yu (43094)

“…<p>(A) Gross front view of hearts from 9-month-old <i>Tie2</i>^<i>Cre+</i><i>;Vgll4</i>^<i>fl/-</i> and <i>Vgll4</i>^<i>fl/-</i> control hearts. …”

DataSheet_1_Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools.pdf by Lucía del Pino-Molina (5213879)

“…These consisted of: i) a normally-appearing maturation pathway with altered levels of expression of >1 (CD38, CD5, CD19, CD21, CD24, and/or smIgM) phenotypic marker (57/88 patients; 65%) for a total of 3 distinct CVID patient profiles (group 1: 42/88 patients, 48%; group 2: 8/88, 9%; and group 3: 7/88, 8%) and ii) CVID patients with a clearly altered pre-GC B cell maturation pathway in blood (group 4: 31/88 cases, 35%).…”

DataSheet_1_Fighting eimeriosis by using the anti-eimerial and anti-apoptotic properties of rhatany root extract.docx by Saleh Al-Quraishy (729945)

“…In vitro anti-eimerial activity of RRE (200, 100, 50 mg/ml), amprolium, phenol, Dettol™, and formalin were studied after incubation with non-sporulated Eimeria oocysts. …”

Loss of <i>Smndc1</i> poison exon alters global transcript and protein abundance, while steady state RNA splicing is modestly affected. by Andrea E. Belleville (19434726)

“…<p><b>A</b>, Quantification of RNA-sequencing (RNA-seq) reads supporting <i>Smndc1</i> poison exon (PE) inclusion. …”

OSCP1 localizes to the cilium and regulates ciliary function in vivo. by Teunis J. P. van Dam (271192)

“…We injected zebrafish embryos at one cell stage with 4 ng of oscp1 morpholino and 100 pg of human OSCP1 mRNA. The rescue increased the normal phenotype percentage from 8% to 43% and decreased the weak phenotype from 51% to 27% and the strong phenotype from 28% to 9.5%. …”

<i>B. bassiana</i>-induced cell loss requires Wek, but Wek has pleiotropic functions. by Deepanshu N. D. Singh (20721878)

“…Asterisks on graphs: * <i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001. Scale bars: (A, D, F) 100 μm. Genotypes: Control: <i>MyD88 GAL4 hisYFP/ + tubGAL80</i>^<i>ts</i><i>/ +</i> flies, whereby the GAL4 driver line was outcrossed to wild-type. …”

Extraction time and mustard concentration for extraction of aquatic oligochaetes by using wet funnel by Satoshi Kaneda (571209)

“…After 5 h of extraction, the residue was moved into the plastic tray, and the remaining individuals in the residue were counted by hand-sorting. In Exp. S1.2, a fresh volume of approximately 100 cc of stock soil which had been collected from the same station was used because the original stock soil sample had already been depleted at that point. …”

Qualitative changes in the implant subgroup. by Adela Klezlova (22608008)

“…</p><p>Results</p><p>Based on the previous results and <i><i>in vitro</i></i> surgical experiences, the implant was narrowed to 2.0 mm, a thickness of 100 µm was chosen, and the implant was fixed with two scleral stitches to maintain its position. …”

Results of the colorimetric MTT test. by Adela Klezlova (22608008)

“…</p><p>Results</p><p>Based on the previous results and <i><i>in vitro</i></i> surgical experiences, the implant was narrowed to 2.0 mm, a thickness of 100 µm was chosen, and the implant was fixed with two scleral stitches to maintain its position. …”

IOP fluctuation. by Adela Klezlova (22608008)

“…</p><p>Results</p><p>Based on the previous results and <i><i>in vitro</i></i> surgical experiences, the implant was narrowed to 2.0 mm, a thickness of 100 µm was chosen, and the implant was fixed with two scleral stitches to maintain its position. …”

IOP fluctuation. by Adela Klezlova (22608008)

“…</p><p>Results</p><p>Based on the previous results and <i><i>in vitro</i></i> surgical experiences, the implant was narrowed to 2.0 mm, a thickness of 100 µm was chosen, and the implant was fixed with two scleral stitches to maintain its position. …”

JAK2, SRC, and EGFR promote Ras phosphorylation at Y4. by Chalita Washington (8997378)

“…Basal recognition of Ras^Y4F protein by anti-pY4 antibodies is decreased compared to Ras^WT protein. (E-H) Full gels of gel slices from <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008715#pgen.1008715.g005" target="_blank">Fig 5B</a>. …”

SEAwise report on Carbon footprint, economic and social impacts of revised management strategies by Isabella Bitetto (20145735)

“…</p><p dir="ltr">The <b>Celtic Sea case study in the Western Waters </b>showed less impact of climate change than management scenario, as some stocks were expected to increase productivity while others decreased productivity. The F_MSY-min and F_MSY-range scenarios resulted in strong reductions of fishing effort for both the LSF and the SSF, and consequently a decline in employment. …”

Inhibition of the NF-κB signaling pathway in adipocytes ameliorates survival of <i>PGRP-LB</i>^<i>Δ</i> mutant flies infected with <i>E</i>. <i>cc</i>. by Bernard Charroux (201413)

“…Flies of the following genotypes were used: <i>w</i>^<i>1118</i>/<i>w</i>^<i>1118</i>; <i>+/+</i> or <i>Mex</i>^<i>Gal4</i><i>/+</i> or <i>cg</i>^<i>Gal4</i><i>/+; PGRP-LB</i>^<i>Δ</i>, <i>Dipt-Cherry</i>^<i>C1</i>/<i>PGRP-LB</i>^<i>Δ</i>, <i>UAS-dFadd</i>^<i>IR</i> (C-D) and <i>w</i>^<i>1118</i>/<i>w</i>^<i>1118</i>;; <i>PGRP-LB</i>^<i>Δ</i>, <i>da</i>^<i>Gal4</i> or <i>PGRP-LB</i>^<i>Δ</i>, <i>Mef2</i>^{<i>Gal4</i> or} <i>PGRP-LB</i>^<i>Δ</i>, <i>r4</i>^<i>Gal4</i>/<i>PGRP-LB</i>^<i>Δ</i>, <i>UAS-dFadd</i>^<i>IR</i> (D). Scale bar is 100 μm (midguts in C) and 20 μm (fat bodies in A and C).…”

Pericardial Cyst by Christopher Komanapalli (13912363)

“…One literature review reported that one third of patients had recurrence after percutaneous drainage at three years. Injection of a sclerosing agent such as alcohol decreases the likelihood of cyst recurrence.…”

Update on trimethylamine N-oxide (TMAO) as a piezolyte and cryoprotectant: its role in a depth limit for marine fishes and loss from hadal fish during capture by Paul Yancey (14354982)

“…</p><p dir="ltr">Jamieson AJ, Yancey PH (2012). doi/10.1086/BBLv222n3p171</p><p dir="ltr">Lantz C, Xi Z, Rider RL, Walker TE, Hebert M, Russell DH (2024). doi.org/10.1021/acs.jpcb.4c04951</p><p dir="ltr">Laurent H, Youngs TGA, Headen TF, Soper AK, Dougan L (2022). doi.org/10.1038/s42004-022-00726-z</p><p dir="ltr">Li X, Wang C, Yanagita T, Xue C, Zhang T, Wang Y (2024). doi.org/10.1021/acs.jafc.4c01974</p><p dir="ltr">Linley T, Gerringer M, Yancey PH, Drazen JC, Weinstock C, Jamieson A (2016). doi.org/10.1016/j.dsr.2016.05.003</p><p dir="ltr">Liu Q, Jiang S, Li W, Pan B, Xu Q (2022). doi.org/10.3390/jmse10040454</p><p dir="ltr">Liu T-H, Okuno M (2024). doi.org/10.1039/D4CP01025F</p><p dir="ltr">Loo RL, Chan Q, Nicholson JK, Holmes E (2022). doi.org/10.1021/acs.jproteome.1c00851</p><p dir="ltr">Mueller-Dieckmann C, Kauffmann B, Weiss MS (2011). doi.org/10.1107/S0021889811000</p><p dir="ltr">Mu Y, Bian C, Liu R, Wang Y, Shao G, Li J, et al. (2021). doi.org/10.1371/journal.pgen.1009530</p><p dir="ltr">Raymond JA, Devries AL (1998). doi.org/10.1023/a:1007778728627</p><p dir="ltr">Raymond JA, Hassel A (2005). doi.org/10.1111/j.1095-8649.2000.tb02240.x</p><p dir="ltr">Roche J, Royer CA (2018). doi.org/10.1098/rsif.2018.0244</p><p dir="ltr">Samerotte AL, Drazen JC, Brand GL, Seibel BA, Yancey PH (2007). doi/10.1086/510566</p><p dir="ltr">Swan JA, Jamieson AJ, Linley TD, Yancey PH (2021). doi.org/10.1093/jcbiol/ruaa102</p><p dir="ltr">Treberg JR, Bystriansky JS, Driedzic WR (2005). doi.org/10.1002/jez.a.140</p><p dir="ltr">Wang K, Shen Y, Yang Y, Gan X, Liu G, Hu K, et al. (2019). doi.org/10.1038/s41559-019-0864-8</p><p dir="ltr">Xu H, Fang C, Xu W, Wang C, Song Y, Zhu C, et al. (2025). doi.org/10.1016/j.cell.2025.01.002</p><p dir="ltr">Yancey PH, Speers-Roesch B, Atchison A, Reist JD., Treberg JR (2018). doi.org/10.1086/696157</p><p dir="ltr">Yancey PH (2020). doi.org/10.1002/jez.2354</p><p dir="ltr">Yancey PH (2023). doi/10.33594/000000661</p>…”

PDLB - Balance Sheet by Nguyen Linh (19516642)

“…Although they scaled the construction business in 2023, it's not a new business for PDLB (they've been doing construction loans on the order of ~100M per year since 2017, and on a smaller scale before that). …”